Lab Management
Population Genetics Technologies Ltd., a company dedicated to the development of innovative approaches for genetic analyses and biomarker discovery, has today launched the Populus Award 2012.
| 2 min read
New plant on its Mourenx, France site to produce a large volume commercial API.
| 2 min read
Life Technologies (NASDAQ: LIFE) today announced the acquisition of Compendia Bioscience, a preeminent cancer bioinformatics company widely used by the pharmaceutical industry to identify novel gene targets for drug discovery and development.
| 3 min read
The Cleveland Fire Department's mobile lab begins and ends with equipment.
| 5+ min read
Three Members of the Whitehead Institute faculty are poised to play significant roles in the establishment of a new stem cell research center.
| 2 min read
TECAN and JPT Peptide Technologies GmbH, a wholly-owned subsidiary of BIONTECH AG, today announced a collaborative agreement between the two specialist companies.
| 1 min read
Engineers and scientists are working together in new ways to invent catalysts that lead to industrial chemicals from biorenewable resources.
| 4 min read
The U.S. Food and Drug Administration recently announced the formation of an internal task force that will support the development of new antibacterial drugs, a critical public health care goal and a priority for the agency.
| 3 min read
Decade of diminishing funding could impact research and education.
| 5 min read
Vanderbilt University and Bristol-Myers Squibb have signed a collaboration agreement for the discovery, development and commercialization of novel therapies acting on the mGluR4 glutamate receptor.
| 2 min read
From the CBST/VIT perspective, teaming up with BIA Separations will give CBST/VIT access to a unique and leading edge technologies and know-how in the field of downstream purification and separations of large bio-molecules.
| 1 min read
The DIY movement has vaulted from the home to the research lab, and it’s driven by the same motives: saving tons of money and getting precisely what you want. It’s spawning a revolution, says Joshua Pearce.
| 3 min read
